Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Guardion Health Sciences | 491 | 2021 | |||||||||
Workhorse Group | 205 | 2023q3 | |||||||||
Abeona Therapeutics | 95 | 2022 | |||||||||
Intra-Cellular Therapies | 8,028 | 2023q3 | |||||||||
ANSYS | 27,983 | 2023q3 | |||||||||
Liberty Broadband | 14,287 | 2023q3 | |||||||||
Nu Holdings | 70,210 | 2021 | |||||||||
Axon Enterprise | 16,213 | 2023q3 | |||||||||
Lattice Semiconductor Cor... | 7,676 | 2023q3 | |||||||||
Terreno Realty | 4,691 | 2023q3 | |||||||||
Gitlab | 9,185 | 2024q3 | |||||||||
Nano-X Imaging | 474 | 2022 | |||||||||
ΠΠΠ‘Π | 142 | 2023 | |||||||||
SIGA Technologies | 483 | 2023q3 | |||||||||
Mesabi Trust | 236 | 2024q3 | |||||||||
Virgin Galactic Holdings | 342 | 2023 | |||||||||
HubSpot | 24,810 | 2023q1 | |||||||||
Intellia Therapeutics | 2,090 | 2024q2 | |||||||||
BioXcel Therapeutics | 17 | 2022 | |||||||||
Verve Therapeutics | 528 | 2023 |